QUALIGEN THERAPEUTICS INC (QLGN) Stock Earnings & Estimates
USA - NASDAQ:QLGN - US74754R3012 - Common Stock
2.81 USD
-0.04 (-1.4%)
2.74 USD
-0.07 (-2.49%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.85M | 5.65M 98.25% | 4.98M -11.86% | 3.264M -100.00% | |||
| EBITDA YoY % growth | -10.43M 3.69% | -22.55M -116.20% | -17.79M 21.11% | N/A 36.48% | N/A | N/A | |
| EBIT YoY % growth | -10.52M 2.95% | -22.66M -115.40% | -17.94M 20.83% | -12.954M 36.98% | -11.22M 0.75% | -11.628M -3.64% | |
| Operating Margin | -369.12% | -401.06% | -360.24% | -396.88% | N/A | N/A | |
| EPS YoY % growth | N/A | -6.10 | N/A -3,662.30% | -2.75 98.80% | -1.02 62.96% | -0.72 29.00% |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | -0.08 92.00% | -0.94 | 0.86 | 91.47% |
| Q2 2023 Q2Q % growth | -0.68 38.18% | -0.53 | -0.15 | -28.21% |
| Q4 2022 Q2Q % growth | 28.60% | -1.43 | % | |
| Q3 2022 Q2Q % growth | -1.00 | -1.33 | 0.33 | 24.59% |
| Q2 2022 Q2Q % growth | -1.10 38.89% | -1.63 | 0.53 | 32.60% |
| Q1 2022 Q2Q % growth | -1.20 7.69% | -1.73 | 0.53 | 30.80% |
| Q4 2021 Q2Q % growth | -2.00 -335.29% | -1.73 | -0.27 | -15.34% |
| Q3 2021 Q2Q % growth | -1.00 -880.39% | -1.99 | 0.99 | 49.72% |
| Q2 2021 Q2Q % growth | -1.80 | -1.63 | -0.17 | -10.29% |
| Q1 2021 Q2Q % growth | -1.30 | -1.43 | 0.13 | 8.96% |
| Q4 2020 Q2Q % growth | 0.85 108.95% | -0.13 | 0.98 | 741.03% |
| Q3 2020 Q2Q % growth | 99.82% | -0.10 | % | |
| Q4 2019 Q2Q % growth | -9.50 | -15.30 | 5.80 | 37.91% |
| Q3 2019 Q2Q % growth | -57.50 | -58.65 | 1.15 | 1.96% |
| Q2 2019 Q2Q % growth | -77.50 | -124.95 | 47.45 | 37.98% |
| Q1 2019 Q2Q % growth | -145.00 | -184.88 | 39.88 | 21.57% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | 426K -70.42% | 510K | -84K | -16.47% |
| Q2 2023 Q2Q % growth | 1.627M 13.78% | 1.632M | -4.97K | -0.30% |
| Q1 2023 Q2Q % growth | 1.61M 123.61% | % | ||
| Q4 2022 Q2Q % growth | 1.39M -6.08% | 1.607M | -217K | -13.50% |
| Q3 2022 Q2Q % growth | 1.44M 24.14% | 1.652M | -212K | -12.83% |
| Q2 2022 Q2Q % growth | 1.43M 27.68% | 1.224M | 206K | 16.83% |
| Q1 2022 Q2Q % growth | 720K -62.11% | 877.71K | -157.71K | -17.97% |
| Q4 2021 Q2Q % growth | 1.48M 33.33% | 1.171M | 309K | 26.39% |
| Q3 2021 Q2Q % growth | 1.16M 38.10% | 1.368M | -208K | -15.20% |
| Q2 2021 Q2Q % growth | 1.12M 24.44% | 1.428M | -308K | -21.57% |
| Q1 2021 Q2Q % growth | 1.9M | 1.224M | 676K | 55.23% |
| Q4 2020 Q2Q % growth | 1.11M | 1.227M | -117.134K | -9.55% |
| Q3 2020 Q2Q % growth | 840K | 1.015M | -174.999K | -17.24% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |